JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB124913

Anti-NMDAR2A antibody [EPR2465(2)]

Be the first to review this product! Submit a review

|

(58 Publications)

Rabbit Recombinant Monoclonal NMDAR2A antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 58 publications.

View Alternative Names

NMDAR2A, GRIN2A, GluN2A, Glutamate [NMDA] receptor subunit epsilon-1, N-methyl D-aspartate receptor subtype 2A, NR2A, hNR2A

6 Images
Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)
  • WB

Lab

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)

Exposure time

Lanes 1 to 2 : 40 seconds
Lanes 3 to 6 : 20 seconds

We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.

We are unsure how to define the extra bands.

All lanes:

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (ab124913) at 1/2000 dilution

Lane 1:

Human brain lysates prepared in RIPA lysis method at 20 µg

Lane 2:

Human brain lysates prepared in 1%SDS Hot lysis method at 20 µg

Lane 3:

Mouse brain lysates prepared in RIPA lysis method at 20 µg

Lane 4:

Mouse brain lysates prepared in 1%SDS Hot lysis method at 20 µg

Lane 5:

Rat brain lysates prepared in RIPA lysis method at 20 µg

Lane 6:

Rat brain lysates prepared in 1%SDS Hot lysis method at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 165 kDa

Observed band size: 165 kDa

false

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)
  • WB

Unknown

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)

Blocking buffer : 5% NFDM/TBST

Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (ab124913) at 1/20000 dilution

All lanes:

Human fetal brain tissue lysate at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 165 kDa

Observed band size: 165 kDa

false

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)
  • WB

Unknown

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)

Blocking buffer : 5% NFDM/TBST

Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (ab124913) at 1/1000 dilution

All lanes:

Human cerebellum tissue lysate at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 165 kDa

Observed band size: 165 kDa

false

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)
  • WB

Unknown

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)

All lanes:

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (ab124913) at 1/1000 dilution

Lane 1:

Mouse brain lysate at 10 µg

Lane 2:

Rat brain lysate at 10 µg

Lane 3:

Human brain lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 165 kDa

false

OI-RD Scanning - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)
  • WB

CiteAb

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)

NMDAR2A western blot using anti-NMDAR2A antibody [EPR2465(2)] ab124913. Publication image and figure legend from Liang, L., Xie, R., et al., 2020, J Neurochem, PubMed 31705656.

ab124913 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab124913 please see the product overview.

Effects of antagonizing homodomain interacting protein kinase 2 on the synaptic toxicity of Sev. (a, b) Golgi staining and quantification of spines in control rats, Sev-treated, A64-treated, and Sev plus A64-treated rats. N = 6 rats per group. (c) Synaptic ultrastructure in hippocampus of control rats, A64-treated, Sev-treated, and Sev plus A64-treated rats. Notice that the decrease in spine number and PSD length were partially rescued by A64. N = 6 rats per group. (d, e) Western blot and quantification of Synaptophysin, post-synaptic density protein 95 (PSD95), calcium/calmodulin-dependent kinase II (CaMKII), phosphorylation of N-methyl-d-aspartate receptor subunit 2 A (pNR2A), NR2A and vesicular inhibitory amino acid transporter (vGAT). Notice that the decrease in Synaptophysin, PSD95, CaMKII, and pNR2A were partially rescued by A64. N = 6 rats per group. (f–h) Open field assay. N = 8 rats per group. (i–k) Elevated plus maze assay. Notice that A64 treatment alleviated the Sev-induced anxiety. N = 8 rats per group. (l–n) Morris water maze test. Notice that A64 treatment partially improved the spatial memory of Sev-treated rats. N = 8 rats per group. Con, control. Sev, Sevoflurane. *p < 0.05. **p < 0.01. ***p < 0.001. ****p < 0.0001. #p < 0.05. One-way anova (a–n). Bar = 10 μm (a) and 200 nm (c).

false

  • Carrier free

    Anti-NMDAR2A antibody [EPR2465(2)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2465(2)

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.</p><p>For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or <a data-tabindex-counter=\"1\" data-tabindex-value=\"none\" href=\"../../technical-resources/protocols/lysate-preparation-for-western-blot\" tabindex=\"-1\">here.</a></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.</p><p>For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or <a data-tabindex-counter=\"1\" data-tabindex-value=\"none\" href=\"../../technical-resources/protocols/lysate-preparation-for-western-blot\" tabindex=\"-1\">here.</a></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>We recommend to use 1%SDS Hot lysis prepare method to get desired Western Blot results.</p><p>For Lysate preparation protocol, please refer to the protocol book in the protocol section and/or <a data-tabindex-counter=\"1\" data-tabindex-value=\"none\" href=\"../../technical-resources/protocols/lysate-preparation-for-western-blot\" tabindex=\"-1\">here.</a></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NMDAR2A also known as GRIN2A is a subunit of the N-methyl-D-aspartate (NMDA) receptor which belongs to the family of ionotropic glutamate receptors. This receptor functions as a ligand-gated ion channel and requires both glutamate and glycine for activation. NMDAR2A has a molecular mass of about 164 kDa. It plays a significant role in synaptic transmission and plasticity and is mainly expressed in the brain particularly in the cerebral cortex and hippocampus. Its expression is important for normal brain function affecting learning and memory.
Biological function summary

NMDAR2A participates in synaptic signaling by forming part of the NMDA receptor complex. As part of this complex NMDAR2A interacts with other receptor subunits such as NR1 and NR2B which together modulate calcium influx into the neuron. This influx is essential for activating downstream signaling pathways that influence synaptic strength. The receptor's activation is tightly regulated which helps to maintain the balance between synaptic excitation and inhibition in the central nervous system.

Pathways

NMDAR2A serves essential roles in the long-term potentiation (LTP) and synaptic plasticity pathways. LTP is a process that strengthens synaptic connections and is important for memory formation. NMDAR2A interacts with proteins like postsynaptic density protein 95 (PSD-95) within these pathways to mediate downstream signaling events. It is also involved in the MAPK/ERK pathway affecting cellular processes such as gene expression differentiation and survival.

NMDAR2A has been associated with epilepsy and schizophrenia. Mutations or altered expression of NMDAR2A can disrupt normal receptor function and contribute to these conditions. It shows links with other proteins such as NR2B where imbalances between different NMDA receptor subunits may exacerbate disease pathology. Understanding how NMDAR2A functions and misfunctions helps in investigating therapeutic targets for these neurological diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed : 20890276, PubMed : 23933818, PubMed : 23933819, PubMed : 23933820, PubMed : 24504326, PubMed : 26875626, PubMed : 26919761, PubMed : 28242877, PubMed : 36117210, PubMed : 38538865, PubMed : 8768735). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the slow phase of excitatory postsynaptic current, long-term synaptic potentiation, and learning (By similarity). Channel activation requires binding of the neurotransmitter L-glutamate to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed : 23933818, PubMed : 23933819, PubMed : 23933820, PubMed : 24504326, PubMed : 26875626, PubMed : 26919761, PubMed : 27288002, PubMed : 28095420, PubMed : 28105280, PubMed : 28126851, PubMed : 28182669, PubMed : 29644724, PubMed : 38307912, PubMed : 8768735). NMDARs mediate simultaneously the potassium efflux and the influx of calcium and sodium (By similarity). Each GluN2 subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, Ca2(+) permeability, and binding to allosteric modulators (PubMed : 26875626, PubMed : 26919761). Participates in the synaptic plasticity regulation through activation by the L-glutamate releaseed by BEST1, into the synaptic cleft, upon F2R/PAR-1 activation in astrocyte (By similarity).
See full target information GRIN2A

Publications (58)

Recent publications for all applications. Explore the full list and refine your search

Addiction neuroscience 15: PubMed40575352

2025

EcoHIV infection effects on cocaine seeking and neuroimmune responses in male mice depend on cocaine exposure pattern.

Applications

Unspecified application

Species

Unspecified reactive species

Mark D Namba,Qiaowei Xie,Kyewon Park,Joshua G Jackson,Jacqueline M Barker

Frontiers in pharmacology 16:1592187 PubMed40453656

2025

The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure.

Applications

Unspecified application

Species

Unspecified reactive species

Shuang Zhao,Wei Zhao,Ziqi Wang,Xiaofei Chen,Fangjiao Zong,Hanting Zhang

Autophagy 21:807-826 PubMed39635882

2024

Upregulation of ISG15 induced by MAPT/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease.

Applications

Unspecified application

Species

Unspecified reactive species

Qian Liu,Xin Wang,Zhi-Ting Fang,Jun-Ning Zhao,Xue-Xiang Rui,Bing-Ge Zhang,Ye He,Rui-Juan Liu,Jian Chen,Gao-Shang Chai,Gong-Ping Liu

Epigenetics 19:2417158 PubMed39460980

2024

MK-801-exposure induces increased translation efficiency and mRNA hyperacetylation of in the mouse prefrontal cortex.

Applications

Unspecified application

Species

Unspecified reactive species

Liting Xue,Jialu Zhao,Xu Liu,Tian Zhao,Ying Zhang,Haihong Ye

Brain research 1845:149284 PubMed39423961

2024

2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Shasha Xu,Jiaou Chen,Chunfei Xu,Ye Xu,Lu Xu,Meiqi Zhao,Tong Xu,Yungang Cao,Peijun Li,Zhao Han

Journal of cellular biochemistry 126:e30664 PubMed39370692

2024

Biochemical Properties of Synaptic Proteins Are Dependent on Tissue Preparation: NMDA Receptor Solubility Is Regulated by the C-Terminal Tail.

Applications

Unspecified application

Species

Unspecified reactive species

Sehoon Won,Colin L Sweeney,Katherine W Roche

eLife 13: PubMed38963323

2024

Hsp47 promotes biogenesis of multi-subunit neuroreceptors in the endoplasmic reticulum.

Applications

Unspecified application

Species

Unspecified reactive species

Ya-Juan Wang,Xiao-Jing Di,Pei-Pei Zhang,Xi Chen,Marnie P Williams,Dong-Yun Han,Raad Nashmi,Brandon J Henderson,Fraser J Moss,Ting-Wei Mu

ACS omega 9:21838-21850 PubMed38799363

2024

Activation of GPR55 Ameliorates Maternal Separation-Induced Learning and Memory Deficits by Augmenting 5-HT Synthesis in the Dorsal Raphe Nucleus of Juvenile Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Ting Sun,Ya-Ya Du,Yong-Qiang Zhang,Qin-Qin Tian,Xi Li,Jiao-Yan Yu,Yan-Yan Guo,Qing-Qing Liu,Le Yang,Yu-Mei Wu,Qi Yang,Ming-Gao Zhao

CNS neuroscience & therapeutics 30:e14611 PubMed38353051

2024

Overexpression of EphB2 in the basolateral amygdala is crucial for inducing visceral pain sensitization in rats subjected to water avoidance stress.

Applications

Unspecified application

Species

Unspecified reactive species

Guang-Bing Duan,Jun-Wen Wang,Hui-Hui Sun,Zhi-Yu Dong,Yan Zhang,Zhen-Xiang Wang,Ye Chen,Ying Chen,Ying Huang,Shu-Chang Xu

Annals of medicine and surgery (2012) 86:831-841 PubMed38333293

2024

Identification of multiomics map and key biomarkers in uveal melanoma with chromosome 3 loss.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Yong,Tengyao Kang,Tingting Li,Sixuan Li,Xuerui Hu,Xiang Yan,Fuzhao Zhang,Jianghua Zheng,Qin Yang
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com